Medication info
TwinTela Tablet 80/5 mg

TwinTela Tablet 80/5 mg

Prescription medicationOral
Ingredient · strength
Telmisartan›80mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Boryung Biopharma Co., Ltd.
Appearance
Biconvex oval dual tablet in white and light blue colors
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201900805 · Approved 2019.02.01 · Insurance code 670501290

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day (e.g., in the morning), if possible. Before administering this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, direct switching to this medicine may be considered if blood pressure is not adequately controlled with an individual component, as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose. (See “3. Patients Requiring Caution” under Precautions for Use.) In patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
Pediatric patients aged 18 years and younger: Administration of this medicine is not recommended because its safety and efficacy have not been established.

Ingredients

Manufacturer
Boryung Biopharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

Essential hypertension is a condition characterized by persistently high blood pressure, which can threaten cardiovascular health. Telmisartan and Amlodipine both work to lower blood pressure and can be used together when sufficient control is not achieved with monotherapy. This combination therapy effectively lowers blood pressure and helps protect the heart and blood vessels. Therefore, it is used for essential hypertension that is challenging to control with Telmisartan or Amlodipine alone.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day (e.g., in the morning), if possible. Before administering this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, direct switching to this medicine may be considered if blood pressure is not adequately controlled with an individual component, as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose. (See “3. Patients Requiring Caution” under Precautions for Use.) In patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

Pediatric patients aged 18 years and younger: Administration of this medicine is not recommended because its safety and efficacy have not been established.

Precautions

This medication should not be used during pregnancy, particularly in the second and third trimesters, as it can pose serious risks to the fetus. Patients with hypersensitivity to the components of this medication, pregnant or breastfeeding women, those with severe liver impairment, and patients with severe hypotension should not be administered this drug. Patients with liver function impairment, valvular heart disease, or reduced kidney function should be particularly cautious when using this medication. Common side effects include dizziness and peripheral edema, but serious side effects may occur infrequently. This medication should not be used during pregnancy, and if pregnancy is confirmed, it should be discontinued immediately and an alternative treatment should be considered. Due to the risk of hypotension, patients with insufficient fluid or salt should correct their condition before taking this medication, and if symptoms of hypotension occur, appropriate measures should be taken immediately. Caution should be exercised when taking potassium supplements or medications containing potassium, as serum potassium levels may rise. Patients with impaired kidney function should take this medication while periodically checking their kidney status through blood tests. This medication may interact with other drugs, so it's essential to inform a doctor or pharmacist if taking other medications. Dizziness or drowsiness may occur, necessitating caution when driving or operating dangerous machinery. In case of overdose, symptoms such as hypotension, heart rhythm abnormalities, and dizziness may appear, requiring immediate medical attention. This medication is not recommended for children as its safety and efficacy have not been adequately established. Elderly patients may have heightened sensitivity to this medication, necessitating careful administration and possible dose adjustments. Store this medication out of reach of children, do not transfer it to another container, and open the packaging just before taking it.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 100 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory abnormalities
  • sensory loss
  • taste disturbances
  • tremor
  • extrapyramidal disorders
  • muscle rigidity
  • visual impairment
  • double vision
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver disease
  • hepatitis
  • jaundice
  • increased liver enzymes
  • itching
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • polymorphous erythema
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal function impairment
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in an opaque container. It is appropriate to store it at room temperature, between 1 to 30 degrees Celsius. This helps maintain the medication's effectiveness over a longer period.

Appearance and packaging

Appearance

Biconvex oval dual tablet in white and light blue colors

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.